Emicizumab treatment in hemophilia A with inhibitors. A case report and cost-minimization analysis of a non-responder to conventional treatment patient

被引：0
|
作者：
Martinez Garcia, M. F. [1 ]
Fernandez Caballero, M. [1 ]
Juarez Gimenez, J. C. [2 ]
Serna Pareja, A. [1 ]
Cerda Sabater, M. [1 ]
Johansson, E. [1 ]
Alvarez Martinez, E. [1 ]
Fernandez Sarmiento, C. [1 ]
Bosch Albareda, F. [1 ]
Santamaria Ortiz, A. [1 ]
机构：
[1] Vall dHebron Univ Hosp, Hemophilia Unit, Hematol Dept, Barcelona, Spain
[2] Vall dHebron Univ Hosp, Hemophilia Unit, Dept Hosp Pharm, Barcelona, Spain
来源：
HAEMOPHILIA | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P191
引用
收藏
页码：131 / 131
页数：1
相关论文
共 50 条
  • [21] Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain
    Laia Alsina
    J. Bruno Montoro
    Pedro Moral Moral
    Olaf Neth
    Marta Ortiz Pica
    Silvia Sánchez-Ramón
    María Presa
    Itziar Oyagüez
    Miguel Ángel Casado
    Luis Ignacio González-Granado
    The European Journal of Health Economics, 2022, 23 : 551 - 558
  • [22] Cost-Minimization Analysis of Treatment of Mild-To-Moderate Hypertension in Morocco
    El Azizi, Ghizlane Berrada
    Ahid, Samir
    Abir-Khalil, Saadia
    Ellouali, Fedoua
    El Majhad, Amine
    D'Ouzzane, Mouna Charif
    Mouram, Sahar
    Boukili, Abdelali
    Cherti, Mohammed
    Hassar, Mohammed
    Cherrah, Yahia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 430 - 431
  • [23] Cost-utility analysis of emicizumab for the treatment of severe hemophilia A patients in Canada
    Yu, Jacky K. K.
    Wong, William W. L.
    Keepanasseril, Arun
    Iorio, Alfonso
    Edginton, Andrea N. N.
    HAEMOPHILIA, 2023, 29 (02) : 488 - 497
  • [24] COST-MINIMIZATION ANALYSIS OF SUBCUTANEOUS ABATACEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN SPAIN
    Ariza-Ariza, R.
    van Walsem, A.
    Canal Fontcuberta, C.
    Roldan Acevedo, C.
    Betegon Nicolas, L.
    Oyagueez Martin, I
    Janssen, K.
    VALUE IN HEALTH, 2013, 16 (07) : A564 - A564
  • [25] Cost-Minimization Analysis of the Treatment of Patients With Metastatic Colorectal Cancer in Greece
    Fragoulakis, Vassilis
    Papagiannopoulou, Vasilia
    Kourlaba, Georgia
    Maniadakis, Nikolaos
    Fountzilas, Georgios
    CLINICAL THERAPEUTICS, 2012, 34 (10) : 2132 - 2142
  • [26] Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease
    Castaman, Giancarlo
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (02) : 59 - 65
  • [27] Minimizing Costs for Dorsal Wrist Ganglion Treatment: A Cost-Minimization Analysis
    Federer, Andrew E.
    Yoo, Minkyoung
    Stephens, Andrew S.
    Nelson, Richard E.
    Steadman, Jesse N.
    Tyser, Andrew R.
    Kazmers, Nikolas H.
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2023, 48 (01): : 9 - 18
  • [28] Acquired hemophilia A and emicizumab for the treatment of bleeding: two case report and a literature review
    Launois, Amelie
    Martin-Toutain, Isabelle
    Devaux, Floriane
    Lambert, Juliette
    Longval, Thomas
    Merabet, Fatiha
    Jaidi, Rym
    Le Dore, Sophie
    Ferre, Emmanuelle
    Rousselot, Philippe
    De Raucourt, Emmanuelle
    Flaujac, Claire
    ANNALES DE BIOLOGIE CLINIQUE, 2024, 82 (03) : 294 - 307
  • [29] A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of skin and skin-structure infections
    Turco, Neil
    Kane-Gill, Sandra
    D'Amico, Frank
    Oleksiuk, Louise-Marie
    Pickering, Aaron
    PHARMACOTHERAPY, 2017, 37 (12): : E200 - E200
  • [30] COST-MINIMIZATION ANALYSIS FOR SOLIQUA IN THE TREATMENT OF T2DM IN TURKIYE
    Duran, C.
    Cansever, M.
    Ileri, S.
    Kahveci, S.
    Caliskan, Z.
    Ozhan, L.
    Kockaya, G.
    Tibet, B.
    Ozturk, F.
    Kurnaz, M.
    Atikeler, K.
    VALUE IN HEALTH, 2024, 27 (12) : S100 - S100
12345